World’s first female sex drug could be just the beginning

Most women with low sexual desire won’t rush to get the first prescription drug to boost female libido when it becomes available on Saturday. But they may have more options down the road.

Addyi is a daily medication that can’t be taken with alcohol or certain other drugs, which will likely limit its use. But experts believe those restrictions could spur development of better treatments for women’s sexual problems after more than a decade of neglect by most of the world’s large drugmakers.

Kim Wallen, a psychology professor at Emory University, says Addyi represents a historic milestone that may open the door to more drugs targeting desire in men and women. Where Viagra and other men’s erectile dysfunction drugs work by increasing blood flow to the genitals, Addyi acts on brain chemicals associated with desire.

“This is the first time that a drug, for either men or women, has been approved strictly to increase sexual desire,” Wallen says. “That legitimizes many other drugs that are in development.”

Treatments for women’s libido issues are an untapped financial opportunity for drugmakers. Analysts estimate the market could be worth over $2 billion, based on academic estimates that between 5 million and 9 million U.S. women may suffer from desire disorders.

But the area hasn’t been a research priority for drugmakers in many years. Beginning in the 1990s, Pfizer, Bayer and Procter & Gamble all studied – then discarded – drugs targeting female libido.

Addyi itself was developed by the German conglomerate, Boehringer Ingelheim, then sold to Sprout Pharmaceuticals after the Food and Drug Administration rejected the medication due to lackluster effectiveness and issues like nausea, fatigue and dizziness.

It took Sprout four years to win FDA approval for Addyi, which acts on brain chemicals associated with mood and appetite. The drug will come with a bold warning label about the risks of fainting if combined with alcohol or certain medications. Additionally, doctors and pharmacists must complete an online certification process to show they understand the drug’s risks.

Dr. Lisa Dabney says several patients have asked her about Addyi, but they generally lose interest after she explains they cannot drink alcohol while taking the daily medication.

“It’s definitely an option that’s going to help patients,” says Dabney, of New York’s Mt. Sinai hospital. “But it’s going to have a limited patient audience because of the alcohol restrictions and the fact that you have to take it every day.”

Still, some women credit the drug with saving their relationships.

Amanda Parrish, 52, had been married for three years when she realized she was avoiding sex with her husband. Her doctor said it was natural to lose sexual interest with age and suggested she try a vibrator. But nothing worked until Parrish enrolled in a trial of Addyi, which was studied in women who report distress due to a lack of libido.

“It just brought me back to where I was as far as being flirty and playful,” says Parrish, who lives in Nashville. “I went back to the days of leaving notes on his window, in his car, on his mirror in the morning.”

Experts generally describe Addyi’s effect as “modest.” In company studies, women taking the drug that’s also called flibanserin reported a slight uptick in sexually satisfying events each month. Their answers to separate questionnaires indicated they experienced a slight increase in desire and a slight decrease in stress.

Analysts from Evercore ISI estimate Addyi could generate sales of $200 million annually. That’s far below the blockbuster numbers once discussed by experts and the $1 billion that Valeant Pharmaceuticals recently agreed to purchase Sprout.

But the buyout has revived interest in a handful of competitors developing alternate treatments. Those products include nasal sprays, injections and antidepressant pills.

It could be years before any of them reach patients. That’s because the field of women’s sexual medicine remains a small one, comprised of tiny companies with limited resources.

Leading the field is Cranbury, N.J.-based Palatin Technologies Inc. which is studying an injectable drug that mimics a hormone linked to sexual arousal.

Unlike Addyi, women would only take the drug when they want to be sexually active. The company’s pen-like injector contains a single dose of bremelanotide, which lasts about eight hours. Where Addyi is absorbed into the entire nervous system, Palatin drug’s targets a specific region of the brain.

Mid-stage trial results suggest the drug could be at least as effective as Addyi without the dangerous interactions with alcohol. Palatin hopes to submit its drug to the FDA in 2017 with a decision in 2018.

Wall Street analysts estimate the drug, if approved, could reach sales around $500 million, according to Piper Jaffray.

In interviews, company executives highlight the differences between their drug and Addyi. But they also acknowledge the trailblazing path paved by their competitor. Palatin CEO Carl Spana says larger drugmakers are again interested in discussing partnerships with his company, after years of doubts about the future of female sex drugs.

“With the approval of Addyi that’s changed and we’ve seen a much larger uptick in the number of companies that want to talk to us,” Spana says.



Trending News on PVDN

  • baja-california-sur-tourism-growthBaja California Sur tourism growth continues despite recent violent events Baja California Sur tourism growth remains strong as nearly two million visitors arrive in early 2025, driven by safety measures and solid hotel occupancy rates. Baja California Sur has seen Baja California Sur tourism growth gather pace in the first half of 2025, drawing nearly two million visitors despite isolated reports of violence. According to…
  • cables-underground-plan-cdmxMexico City Telecommunications Law mandates companies to bury cables underground Mexico City’s new Telecommunications Law mandates burying overhead cables to improve safety, streamline connectivity, and enhance the urban image with a comprehensive cables underground plan. On Thursday, July 10, 2025, Mexico City took a decisive step to modernize its urban landscape and bolster public safety by approving a new Telecommunications and Broadcasting Law that requires…
  • ensenada airportEnsenada international airport project unveiled The Ensenada international airport project will feature a new runway, passenger terminal and commercial zone near Valle de Guadalupe, boosting regional connectivity and tourism with an investment of MXN 5,500 million for the Ensenada international airport. Ensenada will soon join Mexico’s growing network of modern aviation hubs. During the International Civil Airports Council (ACI) congress,…
  • baja california tourist taxGovernment expects 256 million pesos from Baja California Sur tourist tax The Government of Baja California Sur aims to collect up to 256 million pesos in 2025 through the new “Embrace It” foreign visitor contribution, funding infrastructure and sustainability. The Government of Baja California Sur (BCS) plans to raise as much as 256 million pesos in 2025 by expanding a fee charged to international tourists under…
  • texas floodsUS thanks Mexico for sending rescue teams to assist in Texas flood The US government publicly thanked Mexico flood rescue teams for sending firefighters and civil protection specialists to assist search and rescue efforts in Kerrville, Texas, after deadly July 4 weekend floods. The United States government on July 8, 2025, formally thanked Mexico for its swift deployment of emergency personnel to aid search and rescue operations…
  • quintana-roo-sargassum-beaches-report-july-12-2025Sargassum levels hit moderate to excessive on 68% of monitored beaches in Quintana Roo Today, July 12, 2025, 68% of monitored Quintana Roo sargassum beaches report moderate to excessive algae arrivals while 25% remain clean. See the full list of clean and affected shores and learn how authorities are tackling the influx. The annual surge of sargassum has returned to Quintana Roo’s shores, with 68% of monitored beaches reporting…
  • cancun-boosts-tourism-diversification-sargassumCancún boosts tourism diversification to counter sargassum surge Cancún tourism diversification expands beyond beaches to water parks, cultural sites, religious tours and nightlife to tackle sargassum challenges and keep visitors engaged. Cancún’s iconic beaches have long drawn sun-seeking travelers from around the world. This summer, however, an influx of sargassum seaweed threatens that draw. To keep visitor numbers strong and protect local businesses,…
  • guanajuato-free-700-workers-human-trafficking-labor-exploitationGuanajuato Authorities Free 700 Workers in Human Trafficking and Labor Exploitation Case An inter-institutional operation in Dolores Hidalgo freed 700 people from a ranch in a human trafficking and labor exploitation case and led to a narcotics probe. Dolores Hidalgo, Guanajuato - The Guanajuato Attorney General’s Office executed a landmark raid on a rural ranch in Dolores Hidalgo, freeing approximately 700 people who had been subjected to…
  • Volaris Maintains Regular Operations in Puerto Vallarta Despite Strike ThreatNew Volaris Morelia – Puerto Vallarta route boosts tourism Discover how the new Volaris Morelia Puerto Vallarta route will boost tourism, link two top destinations, and foster cultural and economic ties. The government of Mayor Alfonso Martínez Alcázar in Morelia, through the municipal Ministry of Tourism, officially inaugurated a new air connection between Morelia and Puerto Vallarta operated by Volaris. This direct link promises…
  • caribbean-sargassum-forecastCaribbean sargassum predicts 400,000 tons this season impacting coastal ecosystems, reefs and tourism Discover the latest Caribbean sargassum forecast predicting 400,000 tons this season and its impact on coastal ecosystems, reefs and tourism. Mexican coastal communities brace for a historic surge of sargassum seaweed this hurricane season after UNAM researcher Brigitta I. van Tussenbroek warned that an estimated 400,000 tons of the algae will arrive on the Caribbean…